|
|
|
|
|
|
31 March 2026
EFPIA statement on the conclusions of the EU-India Free Trade Agreement (FTA) negotiations
EFPIA welcomes the EU’s continued efforts to strengthen trade ties with strategic partners at a time of growing geopolitical...
|
||
|
|
30 March 2026
When Chemical policy meets patient care: Why the PFAS debate needs a closer look at medicines...
Europe is in the middle of one of the most ambitious chemical regulatory debates in its history.
|
||
|
|
|
|||||||||
|
|
European health and social care systems are under intense pressure.
With strained budgets, growing pressure on public finances, a deepening workforce crisis, and an uncertain geopolitical landscape, the need to rethink healthcare in Europe has never been more urgent. Join us on 21 April to discuss how Health Checks for cardiometabolic risk factors can transform prevention, reduce avoidable disease, and lower long-term costs. Discover the programme and register here.
|
|
|
Drugmakers delay some European launches with a wary eye on Trump's pricing policies
31 March 2026 (Reuters)
Drugmakers are delaying launches of some new medicines in Europe as the industry grapples with U.S. pressure and...
|
|
Europe’s wastewater Rubik’s Cube: Can Commission and industry align data?
27 March 2026 (Euractiv)
Safeguarding Europe’s water quality has become an increasingly fraught policy challenge as regulators attempt to...
|
|
Czech minister warns EU, wastewater rules risk limiting medicines access
27 March 2026 (Euractiv)
Prague calls on the European Commission and member states to reconsider environmental obligations amid fears of medicine...
|
|
The Most Favored Nation Policy: early insights into Europe’s response
25 March 2026 (Pharmaceutical Technology)
GlobalData analysed the product launch and withdrawal trends using its Price Intelligence (POLI) database, comparing...
|
|
|||
|
|||||
|
EFPIA 2026 All rights reserved ·
Disclaimer
·
|